share

Hypercalcemia Of Malignancy Factor (107-139) (Human) CAS NO 137348-10-8


Unit Price:

CAS No.:137348-10-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Hypercalcemia Of Malignancy Factor (107-139) (Human) CAS NO 137348-10-8 is a defined synthetic peptide fragment corresponding to a specific region of the parathyroid hormone-related protein (PTHrP). This compound is a critical research tool for investigating the mechanisms of humoral hypercalcemia of malignancy (HHM), a common paraneoplastic syndrome. It is primarily utilized by pharmaceutical researchers, academic institutions, and diagnostic developers focused on oncology, endocrinology, and bone metabolism.

Application

  • Biomedical Research: Fundamental studies on the pathophysiology of cancer-induced hypercalcemia and PTHrP signaling pathways.
  • Assay Development: Used as a reference standard or calibrant in the development of immunoassays (e.g., ELISA) to detect PTHrP or related antibodies.
  • Drug Discovery: Screening and validation of potential therapeutic compounds designed to inhibit PTHrP activity or its receptor binding.
  • Antibody Production: Acts as an immunogen for generating specific polyclonal or monoclonal antibodies against the PTHrP (107-139) epitope.
  • Cell Biology Studies: Investigation of the peptide's effects on osteoclast activity, bone resorption, and calcium homeostasis in cell culture models.
  • Quality Control: Serves as a system suitability standard in analytical methods for related peptide-based pharmaceuticals or diagnostics.

Basic Information

Product Name Hypercalcemia Of Malignancy Factor (107-139) (Human)
CAS No. 137348-10-8
Molecular Formula C164H263N51O48S
Molecular Weight 3758.2 g/mol (theoretical)
Synonyms PTHrP (107-139), Human; Parathyroid Hormone-Related Protein (107-139); Hypercalcemic Factor of Malignancy (107-139); PTHLH (107-139); HHM Factor (107-139); PTHRP Fragment 107-139; Cancer-derived Hypercalcemic Peptide
EINECS Contact for details

Quality Control

Our Hypercalcemia Of Malignancy Factor (107-139) (Human) is produced and analyzed under strict quality systems. Each batch undergoes rigorous testing to ensure high purity, correct sequence, and biological relevance. Standard analytical techniques include reversed-phase HPLC, mass spectrometry (MS), and amino acid analysis. A comprehensive Certificate of Analysis (COA) detailing purity, peptide content, and analytical data is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store desiccated at -20°C or below. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to prevent condensation and moisture uptake.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (HPLC) Retention time corresponds to reference standard
Identification (MS) Molecular weight confirmed
Purity (HPLC) ≥ 95%
Peptide Content ≥ 80% (by weight)
Amino Acid Sequence H-Ser-Ala-Leu-Leu-Gln-His-Asp-Lys-Trp-Leu-Asn-His-Leu-Gln-Leu-Leu-Ala-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asn-OH
Solubility Soluble in water or dilute acetic acid

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.